Healthcare resources and costs associated with nonvalvular atrial fibrillation in Spain: apixaban versus acenocoumarol
JC Colet, AS Mainar… - Journal of …, 2023 - becarispublishing.com
Aim: Healthcare resources usage and costs associated to nonvalvular atrial fibrillation
(NVAF) were analyzed in Spain. Methods: This is an observational and retrospective study …
(NVAF) were analyzed in Spain. Methods: This is an observational and retrospective study …
Healthcare resources and costs associated with nonvalvular atrial fibrillation in Spain: apixaban versus acenocoumarol
J Comín Colet, A Sicras Mainar… - Journal of comparative …, 2023 - docusalut.com
Aim: Healthcare resources usage and costs associated to nonvalvular atrial fibrillation
(NVAF) were analyzed in Spain. Methods: This is an observational and retrospective study …
(NVAF) were analyzed in Spain. Methods: This is an observational and retrospective study …
[HTML][HTML] Healthcare resources and costs associated with nonvalvular atrial fibrillation in Spain: apixaban versus acenocoumarol
JC Colet, AS Mainar… - Journal of …, 2023 - ncbi.nlm.nih.gov
Aim: Healthcare resources usage and costs associated to nonvalvular atrial fibrillation
(NVAF) were analyzed in Spain. Methods: This is an observational and retrospective study …
(NVAF) were analyzed in Spain. Methods: This is an observational and retrospective study …
Healthcare resources and costs associated with nonvalvular atrial fibrillation in Spain: apixaban versus acenocoumarol.
JC Colet, AS Mainar… - Journal of …, 2023 - europepmc.org
Aim: Healthcare resources usage and costs associated to nonvalvular atrial fibrillation
(NVAF) were analyzed in Spain. Methods: This is an observational and retrospective study …
(NVAF) were analyzed in Spain. Methods: This is an observational and retrospective study …
Healthcare resources and costs associated with nonvalvular atrial fibrillation in Spain: apixaban versus acenocoumarol
JC Colet, AS Mainar… - … Research, 2023, vol …, 2023 - diposit.ub.edu
Aim: Healthcare resources usage and costs associated to nonvalvular atrial fibrillation
(NVAF) were analyzed in Spain. Methods: This is an observational and retrospective study …
(NVAF) were analyzed in Spain. Methods: This is an observational and retrospective study …
Healthcare resources and costs associated with nonvalvular atrial fibrillation in Spain: apixaban versus acenocoumarol
JC Colet, AS Mainar… - Journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Aim: Healthcare resources usage and costs associated to nonvalvular atrial fibrillation
(NVAF) were analyzed in Spain. Methods: This is an observational and retrospective study …
(NVAF) were analyzed in Spain. Methods: This is an observational and retrospective study …
Healthcare resources and costs associated with nonvalvular atrial fibrillation in Spain: apixaban versus acenocoumarol.
JC Colet, AS Mainar… - Journal of …, 2023 - europepmc.org
Aim: Healthcare resources usage and costs associated to nonvalvular atrial fibrillation
(NVAF) were analyzed in Spain. Methods: This is an observational and retrospective study …
(NVAF) were analyzed in Spain. Methods: This is an observational and retrospective study …